Literature DB >> 31443979

Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients.

Anne Jouinot1, Guillaume Ulmann2, Clara Vazeille3, Jean-Philippe Durand4, Pascaline Boudou-Rouquette3, Jennifer Arrondeau3, Camille Tlemsani3, Ludovic Fournel5, Marco Alifano5, Marie Wislez6, Jeanne Chapron6, Camille Le Bris3, Audrey Mansuet-Lupo7, Diane Damotte7, Nathalie Neveux2, Jean-Pascal De Bandt2, Jérôme Alexandre3, Luc Cynober2, François Goldwasser4.   

Abstract

BACKGROUND & AIMS: Metastatic non-small cell lung cancer (NSCLC) is the first cause of cancer death worldwide. Increased resting energy expenditure (REE) is frequent among cancer patients and may contribute to cancer cachexia. The aim of this study was to examine the prognostic value of increased REE in metastatic NSCLC patients.
METHODS: This observational study was conducted between June 2012 and November 2017 in the outpatient unit of the oncology department of Cochin hospital, Paris. Consecutive patients with newly diagnosed stage IV NSCLC underwent measurement of REE by indirect calorimetry before treatment initiation. Uni- and multivariate analysis of overall survival (OS, Cox models) included age, sex, smoking habit, histological subtype, performance status, body mass index, weight loss, albumin and CRP levels and the ratio of measured REE to the REE predicted by the Harris Benedict formula (mREE/pREE).
RESULTS: 144 patients were enrolled: mean age 64 years, 63% male, 90% non-squamous carcinoma, including 17% with ALK/EGFR alteration. In univariate analysis, tobacco consumption (p = 0.007), histo-molecular subtype (p < 10-3), performance status (p = 0.04), weight loss (p < 10-4), albumin (p < 10-4), CRP (p = 0.001) and mREE/pREE ratio (>vs ≤ 120%: HR = 2.16, p < 10-3) were significant prognostic factors of OS. Median OS were 6.1 and 17.3 months in patients with mREE/pREE ratio > and ≤120%, respectively. In multivariate analysis, histo-molecular subtype (non-squamous ALK/EGFR mutated vs squamous carcinoma: HR = 0.25, p = 0.006), weight loss (>vs ≤ 5%: HR = 1.98, p = 0.004), albumin (≥vs < 35 g/L: HR = 0.56, p = 0.02) and mREE/pREE ratio (> vs ≤120%: HR = 1.90, p = 0.004) were identified as independent prognostic factors.
CONCLUSIONS: Elevated resting energy expenditure emerges as an independent prognostic factor in metastatic NSCLC.
Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Malnutrition; Non-small cell lung cancer; Prognosis; Resting energy expenditure; Survival

Year:  2019        PMID: 31443979     DOI: 10.1016/j.clnu.2019.08.003

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  7 in total

1.  Early-Onset Physical Inactivity and Metabolic Dysfunction in Tumor-bearing Mice Is Associated with Accelerated Cachexia.

Authors:  Brittany R Counts; Jessica L Halle; James A Carson
Journal:  Med Sci Sports Exerc       Date:  2022-01-01       Impact factor: 5.411

2.  Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab.

Authors:  Johanna Noel; Anne Jouinot; Jérôme Alexandre; Guillaume Ulmann; Marie Bretagne; Zahra Castel-Ajgal; Sixtine De Percin; Clémentine Vaquin-Villeminey; Marie-Pierre Revel; Michael Peyromaure; Pascaline Boudou-Rouquette; Jennifer Arrondeau; Ithar Gataa; Jean-Philippe Durand; François Goldwasser; Olivier Huillard
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

3.  One-Year Mortality in Patients with Cancer Cachexia: Association with Albumin and Total Protein.

Authors:  Xiao-Yue Liu; Xi Zhang; Guo-Tian Ruan; Kang-Ping Zhang; Meng Tang; Qi Zhang; Meng-Meng Song; Xiao-Wei Zhang; Yi-Zhong Ge; Ming Yang; Hong-Xia Xu; Chun-Hua Song; Han-Ping Shi
Journal:  Cancer Manag Res       Date:  2021-08-29       Impact factor: 3.989

Review 4.  Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration.

Authors:  Marc Beltrà; Fabrizio Pin; Riccardo Ballarò; Paola Costelli; Fabio Penna
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

5.  Low-protein diet applied as part of combination therapy or stand-alone normalizes lifespan and tumor proliferation in a model of intestinal cancer.

Authors:  Alina Proske; Judith Bossen; Jakob von Frieling; Thomas Roeder
Journal:  Aging (Albany NY)       Date:  2021-11-12       Impact factor: 5.682

Review 6.  Cancer Cachexia and Related Metabolic Dysfunction.

Authors:  Guilherme Wesley Peixoto da Fonseca; Jerneja Farkas; Eva Dora; Stephan von Haehling; Mitja Lainscak
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

7.  [Prognostic Factors of N2 Stage Non-small Cell Lung Cancer after Surgery].

Authors:  Zhenyu Yang; Shiyou Wei; Liang Xia; Lunxu Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.